Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The co...
Quick-Med Technologies reported revenue of $928,493 for fiscal year 2013, down 6.9% from fiscal year 2012, and net income of -$713,073.
Figures from company filings; latest fiscal year ended June 30, 2013.
No profile data available.